EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 310 filers reported holding EDITAS MEDICINE INC in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,085,229 | -19.4% | 1,164,773 | -15.0% | 0.01% | -16.7% |
| Q2 2023 | $11,273,635 | +121004.7% | 1,369,822 | +6.7% | 0.01% | +20.0% |
| Q1 2023 | $9,309 | -51.0% | 1,283,937 | -40.1% | 0.01% | -54.5% |
| Q4 2022 | $19,004 | -99.9% | 2,142,468 | +13.8% | 0.01% | -21.4% |
| Q3 2022 | $23,046,000 | +1188.9% | 1,882,870 | +1145.6% | 0.01% | +1300.0% |
| Q2 2022 | $1,788,000 | -87.4% | 151,160 | -79.8% | 0.00% | -87.5% |
| Q1 2022 | $14,221,000 | -45.8% | 747,661 | -24.3% | 0.01% | -38.5% |
| Q4 2021 | $26,239,000 | +911.1% | 988,290 | +1464.4% | 0.01% | +1200.0% |
| Q3 2021 | $2,595,000 | +52.7% | 63,174 | +110.6% | 0.00% | 0.0% |
| Q2 2021 | $1,699,000 | -82.0% | 30,000 | -86.7% | 0.00% | -85.7% |
| Q1 2021 | $9,447,000 | +124.1% | 224,919 | +274.1% | 0.01% | +133.3% |
| Q4 2020 | $4,215,000 | +42.0% | 60,125 | -40.1% | 0.00% | -25.0% |
| Q2 2020 | $2,969,000 | +333.4% | 100,361 | +190.6% | 0.00% | +100.0% |
| Q1 2020 | $685,000 | -66.0% | 34,531 | -49.3% | 0.00% | -33.3% |
| Q4 2019 | $2,017,000 | +40.4% | 68,104 | +7.7% | 0.00% | +50.0% |
| Q3 2019 | $1,437,000 | +37.5% | 63,207 | +49.7% | 0.00% | 0.0% |
| Q2 2019 | $1,045,000 | -66.2% | 42,225 | -66.6% | 0.00% | -60.0% |
| Q1 2019 | $3,092,000 | +85.6% | 126,466 | +72.7% | 0.01% | +66.7% |
| Q4 2018 | $1,666,000 | -83.8% | 73,243 | -76.4% | 0.00% | -78.6% |
| Q1 2018 | $10,280,000 | -20.9% | 310,109 | -26.6% | 0.01% | -22.2% |
| Q4 2017 | $12,991,000 | +44.9% | 422,757 | +13.2% | 0.02% | +28.6% |
| Q3 2017 | $8,966,000 | +224.5% | 373,421 | +126.8% | 0.01% | +180.0% |
| Q2 2017 | $2,763,000 | -78.1% | 164,648 | -70.8% | 0.01% | -78.3% |
| Q1 2017 | $12,604,000 | +7314.1% | 564,699 | +5278.6% | 0.02% | – |
| Q4 2016 | $170,000 | -68.5% | 10,499 | -73.8% | 0.00% | -100.0% |
| Q3 2016 | $539,000 | +41.1% | 40,000 | +155.4% | 0.00% | 0.0% |
| Q2 2016 | $382,000 | – | 15,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |